Silo Wellness Inc. a wellness company in the psychedelics and functional mushroom marketplaces, regrets to announce the passing of board member, Maurice ‘Moe’ Colson, who passed away on March 26, 2021. “It is with great sadness that I announce the recent passing of our Board colleague, Moe Colson,” stated Douglas K. Gordon, Chief Executive Officer of Silo Wellness. “Moe is remembered as a good friend, …
Silo Wellness Inc. (CSE: SILO), a wellness company in the psychedelics and functional mushroom marketplaces, regrets to announce the passing of board member, Maurice ‘Moe’ Colson, who passed away on March 26, 2021.
“It is with great sadness that I announce the recent passing of our Board colleague, Moe Colson,” stated Douglas K. Gordon, Chief Executive Officer of Silo Wellness. “Moe is remembered as a good friend, devoted husband, father and grandfather as well as trusted advisor.”
Mr. Colson served as board member while at Silo Wellness, since the completion of the company’s successful RTO transaction with Yukoterre Resources Inc., in early March of this year. An investment banker, Mr. Colson served as company director for Yukoterre since May 2019. After more than three decades of experience in domestic and international capital markets, Moe was instrumental in helping to transform Silo Wellness into a publicly-traded company on the Canadian Securities Exchange (CSE).
“I was saddened to learn that our friend and colleague Moe Colson had passed away,” added Ryan Ptolemy, Chief Financial Officer with Silo Wellness. “For many years, I worked with Moe, who was such a great person and a friend.”
About Silo Wellness
The mission of Silo Wellness is to improve health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion. Silo Wellness intends to introduce new, safe and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal by conducting ketamine and psilocybin wellness retreats and elsewhere by manufacturing and distributing functional mushrooms.
Since its inception, Silo Wellness’ activities have focused on: (1) development of psilocybin-free functional mushroom tinctures; (2) the development of the formulation of a psilocybin nasal spray in Jamaica; and (3) offering of Jamaican and Oregon psychedelic wellness retreats as well as the cultivation of psychedelic mushrooms in Jamaica. None of Silo Wellness’ products claim to cure or mitigate any physical or mental disease, symptoms, disorders or abnormalities.
For further information, please contact: www.SiloWellness.com
Stuart Kirby, VP of Marketing & Communications
Silo Wellness Investor Relations:
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. Other than statements of historical fact, all statements are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to the business plans of Silo Wellness. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties and the potential impact of COVID-19. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.
Readers should not place undue reliance on the forward-looking statements and information contained in this news release. Silo Wellness assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
News Provided by GlobeNewswire via QuoteMedia